LAVAL, Quebec Nov. 2, 2017 /PRNewswire/ — Ortho Dermatologics, a division of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for IDP-118 (halobetasol propionate and….
AMMAN — Sixty-one international non-governmental organisations (INGOs) working in Jordan have called for stronger international solidarity and responsibility towards the refugee crisis, urging both the […]
A Canadian Search and Rescue pilot received international recognition in London, England Thursday night for work he did last winter while he was based in […]
Purchase: Order Reprint PHOENIX — Vice President Mike Pence is traveling to Arizona Wednesday as the state sees skyrocketing coronavirus infections and hospitals prepare for […]
VACANCY ANNOUNCEMENT. Executive Director African Economic Research Consortium (AERC) SRI Executive Search has been contracted by the African Economic Research Consortium (AERC) to assist with […]